|
1
|
Moss JW and Ramji DP: Cytokines: Roles in
atherosclerosis disease progression and potential therapeutic
targets. Future Med Chem. 8:1317–1330. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Libby P, Ridker PM and Hansson GK:
Progress and challenges in translating the biology of
atherosclerosis. Nature. 473:317–325. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Glass CK and Witztum JL: Atherosclerosis.
Cell. 104:503–516. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Horton JD, Cohen JC and Hobbs HH:
Molecular biology of PCSK9: Its role in LDL metabolism. Trends
Biochem Sci. 32:71–77. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hedrick JA: Targeting PCSK9 for the
treatment of hypercholesterolemia. Curr Opin Invest Drugs.
10:938–946. 2009.
|
|
6
|
Xu YJ, Zheng L, Hu YW and Wang Q:
Pyroptosis and its relationship to atherosclerosis. Clin Chim Acta.
476:28–37. 2018. View Article : Google Scholar
|
|
7
|
Hoseini Z, Sepahvand F, Rashidi B,
Sahebkar A, Masoudifar A and Mirzaei H: NLRP3 inflammasome: Its
regulation and involvement in atherosclerosis. J Cell Physiol.
233:2116–2132. 2018. View Article : Google Scholar
|
|
8
|
Shah PK and Lecis D: Inflammation in
atherosclerotic cardiovascular disease. F1000Res. 8:F10002019.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhaolin Z, Jiaojiao C, Peng W, Yami L,
Tingting Z, Jun T, Shiyuan W, Jinyan X, Dangheng W, Zhisheng J and
Zuo W: OxLDL induces vascular endothelial cell pyroptosis through
miR-125a-5p/TET2 pathway. J Cell Physiol. 234:7475–7491. 2019.
|
|
10
|
Mottis A, Herzig S and Auwerx J:
Mitocellular communication: Shaping health and disease. Science.
366:827–832. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ding Z, Liu S, Wang X, Deng X, Fan Y, Sun
C, Wang Y and Mehta JL: Hemodynamic shear stress via ROS modulates
PCSK9 expression in human vascular endothelial and smooth muscle
cells and along the mouse aorta. Antioxid Redox Signal. 22:760–771.
2015. View Article : Google Scholar :
|
|
12
|
Bao HL, Liao FJ, Fang L, Zhong F, Liu W
and Li JQ: Effect and mechanism of PCSK9 on lectin-like oxidized
low-density lipoprotein receptor-1 mediated oxidized low-density
lipoprotein uptake by THP-1 derived macrophages. Zhonghua Xin Xue
Guan Bing Za Zhi. 47:367–373. 2019.In Chinese. PubMed/NCBI
|
|
13
|
Wu CY, Tang ZH, Jiang L, Li XF, Jiang ZS
and Liu LS: PCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL
via bcl/Bax-caspase9-caspase3 pathway. Mol Cell Biochem.
359:347–358. 2012. View Article : Google Scholar
|
|
14
|
Chen JJ, Tao J, Zhang XL, Xia LZ, Zeng JF,
Zhang H, Wei DH, Lv YC, Li GH and Wang Z: Inhibition of the
ox-LDL-induced pyroptosis by FGF21 of human umbilical vein
endothelial cells through the TET2-UQCRC1-ROS pathway. DNA Cell
Biol. 39:661–670. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Davies PF: Hemodynamic shear stress and
the endothelium in cardiovascular pathophysiology. Nat Clin Pract
Cardiovasc Med. 6:16–26. 2009. View Article : Google Scholar
|
|
16
|
Zhang L, Yuan M, Zhang L, Wu B and Sun X:
Adiponectin alleviates NLRP3-inflammasome-mediated pyroptosis of
aortic endothelial cells by inhibiting FoxO4 in arteriosclerosis.
Biochem Biophys Res Commun. 514:266–272. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chang W, Lin J, Dong J and Li D:
Pyroptosis: An inflammatory cell death implicates in
atherosclerosis. Med Hypotheses. 81:484–486. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou R, Yazdi AS, Menu P and Tschopp J: A
role for mitochondria in NLRP3 inflammasome activation. Nature.
469:221–225. 2011. View Article : Google Scholar
|
|
19
|
Lin XL, Xiao LL, Tang ZH, Jiang ZS and Liu
MH: Role of PCSK9 in lipid metabolism and atherosclerosis. Biomed
Pharmacother. 104:36–44. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vozenilek AE, Vetkoetter M, Green JM, Shen
X, Traylor JG, Klein RL, Orr AW and Woolard MD: Absence of
nicotinamide nucleotide transhydrogenase in C57BL/6J mice
exacerbates experimental atherosclerosis. J Vasc Res. 55:98–110.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ruscica M, Ferri N, Corsini A and Sirtori
CR: PCSK9 antagonists and inflammation. Atherosclerosis.
268:235–236. 2018. View Article : Google Scholar
|
|
22
|
Aarreberg LD, Esser-Nobis K, Driscoll C,
Shuvarikov A, Roby JA and Gale M Jr: Interleukin-1β induces mtDNA
release to activate innate immune signaling via cGAS-STING. Mol
Cell. 74:801–815 e806. 2019. View Article : Google Scholar
|
|
23
|
He X, Wang L, Chen XF, Liang Q, Wang WQ,
Lin AQ, Yi L, Wang Y and Gao Q: Metformin improved oxidized
low-density lipoprotein-impaired mitochondrial function and
increased glucose uptake involving akt-AS160 pathway in raw264.7
macro-phages. Chin Med J (Engl). 132:1713–1722. 2019. View Article : Google Scholar
|
|
24
|
Thonusin C, Apaijai N, Jaiwongkam T,
Kerdphoo S, Arunsak B, Amput P, Palee S, Pratchayasakul W,
Chattipakorn N and Chattipakorn SC: The comparative effects of high
dose atorvastatin and proprotein convertase subtilisin/kexin type 9
inhibitor on the mitochondria of oxidative muscle fibers in
obese-insulin resistant female rats. Toxicol Appl Pharmacol.
382:1147412019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ding Z, Pothineni NVK, Goel A, Luscher TF
and Mehta JL: PCSK9 and inflammation: Role of shear stress,
pro-inflammatory cytokines, and LOX-1. Cardiovasc Res. 116:908–915.
2020. View Article : Google Scholar
|
|
26
|
Ding Z, Liu S, Wang X, Mathur P, Dai Y,
Theus S, Deng X, Fan Y and Mehta JL: Cross-Talk between PCSK9 and
damaged mtDNA in vascular smooth muscle cells: Role in apoptosis.
Antioxid Redox Signal. 25:997–1008. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Massaad CA and Klann E: Reactive oxygen
species in the regulation of synaptic plasticity and memory.
Antioxid Redox Signal. 14:2013–2054. 2011. View Article : Google Scholar :
|
